Allianz Asset Management GmbH - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 129 filers reported holding CARA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$323,000
-41.6%
14,909
-64.4%
0.00%
-100.0%
Q1 2020$553,000
-33.9%
41,857
-19.3%
0.00%0.0%
Q4 2019$836,000
+10.4%
51,865
+25.3%
0.00%0.0%
Q3 2019$757,000
-65.3%
41,398
-59.1%
0.00%
-50.0%
Q2 2019$2,179,000
-10.6%
101,339
-18.4%
0.00%0.0%
Q1 2019$2,437,000
+51.6%
124,234
+0.3%
0.00%0.0%
Q4 2018$1,607,000
-37.4%
123,801
+15.5%
0.00%0.0%
Q3 2018$2,567,000
+36.8%
107,175
+9.4%
0.00%0.0%
Q2 2018$1,876,000
+53.8%
97,938
-0.6%
0.00%
+100.0%
Q1 2018$1,220,000
-0.8%
98,508
-2.0%
0.00%0.0%
Q4 2017$1,230,000
-11.8%
100,478
-1.3%
0.00%0.0%
Q3 2017$1,394,000
-11.2%
101,807
-0.2%
0.00%
-50.0%
Q2 2017$1,570,000
-29.2%
102,025
-15.4%
0.00%0.0%
Q1 2017$2,218,000
-8.3%
120,634
-53.7%
0.00%0.0%
Q4 2016$2,420,000
-23.3%
260,459
-31.0%
0.00%
-33.3%
Q3 2016$3,154,000
+82.0%
377,743
+4.9%
0.00%
+50.0%
Q2 2016$1,733,000
-36.9%
360,245
-18.4%
0.00%
-33.3%
Q1 2016$2,747,000
-63.3%
441,618
-0.5%
0.00%
-62.5%
Q4 2015$7,480,000
+174.2%
443,636
+132.4%
0.01%
+166.7%
Q3 2015$2,728,000190,8860.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders